Stable liquid pharmaceutical formulation of IGG antibodies

Details for Australian Patent Application No. 2002363339 (hide)

Owner PDL BioPharma, Inc.

Inventors Kaisheva, Elizabet A; Duvur, Shanti G; Subramanian, Malathy; Gupta, Supriya

Agent Davies Collison Cave

Pub. Number AU-B-2002363339

PCT Number PCT/US02/36093

PCT Pub. Number WO2003/039485

Priority 60/337,509 08.11.01 US

Filing date 8 November 2002

Wipo publication date 19 May 2003

Acceptance publication date 7 February 2008

International Classifications

A61K 47/08 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing oxygen

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

19 June 2003 Complete Application Filed

  Priority application(s): 60/337,509 08.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363339

26 October 2006 Change of Name(s) of Applicant(s), Section 104

  Protein Design Labs The name of the applicant has been changed to PDL BioPharma, Inc. 2003

7 February 2008 Application Accepted

  Published as AU-B-2002363339

5 June 2008 Standard Patent Sealed

22 October 2009 Assignment Registered

  PDL BioPharma, Inc. The patent has been assigned to Facet Biotech Corporation

3 February 2011 Alteration of Name

  The name of the patentee has been altered to Abbott Biotherapeutics Corp. 2003 Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363340-ELECTRIC SWITCH

2002363338-DIAGNOSTICS AND THERAPEUTICS FOR OCULAR ABNORMALITIES